Delpor, Inc. Employee Directory
Biotechnology ResearchCalifornia, United States2-10 Employees
Delpor, Inc. is a small clinical-stage biotechnology company based in Brisbane, California, focused on medical technology for drug delivery. The company develops therapeutic products and utilizes a technology designed to provide sustained drug release for one year or longer. This approach aims to enable complete medication adherence after a single administration and to improve the efficacy of drugs with short half-lives. Clinical validation has included a phase 2 study of DLP-114, a once-yearly risperidone product for schizophrenia maintenance, with positive safety, efficacy, and PK data, and the company has gathered market research input from over 200 prescribing physicians and several payers in the US and EU. Delpor’s pipeline targets CNS/psychiatric conditions, chronic pain, autoimmune diseases, and other conditions, with ongoing development in areas such as schizophrenia, Opioid Use Disorder, Spasticity, Parkinson’s, Fibromyalgia, MS, Crohn’s, RA, and Lupus.